2023
Machine learning to predict bacteriologic confirmation of Mycobacterium tuberculosis in infants and very young children
Smith J, Milligan K, McCarthy K, Mchembere W, Okeyo E, Musau S, Okumu A, Song R, Click E, Cain K. Machine learning to predict bacteriologic confirmation of Mycobacterium tuberculosis in infants and very young children. PLOS Digital Health 2023, 2: e0000249. PMID: 37195976, PMCID: PMC10191346, DOI: 10.1371/journal.pdig.0000249.Peer-Reviewed Original ResearchMicrobial confirmationTB diseaseYoung childrenNoninvasive procedureLarge prospective cohortCases of tuberculosisChest X-rayDiagnosis of tuberculosisClinical decision makingBacteriologic confirmationHousehold contactsTB infectionProspective cohortRadiologic factorsPaucibacillary natureClinical similaritiesDiagnostic cohortClinical diseaseChildhood diseasesInvasive proceduresNovel biomarkersTuberculosisClinical researchM. tuberculosisDisease
2020
Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.
Hsieh YL, Jahn A, Menzies NA, Yaesoubi R, Salomon JA, Girma B, Gunde L, Eaton JW, Auld A, Odo M, Kiyiika CN, Kalua T, Chiwandira B, Mpunga JU, Mbendra K, Corbett L, Hosseinipour MC, Cohen T, Kunkel A. Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2020, 85: 643-650. PMID: 33177475, PMCID: PMC8564780, DOI: 10.1097/qai.0000000000002497.Peer-Reviewed Original ResearchConceptsIsoniazid preventive therapyIPT programIPT strategyPreventive therapyContinuous isoniazid preventive therapyMore TB casesHIV-positive adultsCases of tuberculosisAnticipated health effectsComparable health benefitsHIV/AIDSCause deathAntiretroviral therapyTB casesTB controlTB incidenceDrug costsMalawi MinistryMean reductionTuberculosisMycobacterium tuberculosisTherapyAnticipated health impactsHealth effectsHealth benefits
2019
Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required
Puga M, Bandeira L, Pompilio M, de Rezende G, Soares L, de Castro V, Tanaka T, Cesar G, de Oliveira S, Teles S, Yassuda R, dos Santos Weis-Torres S, Basílio S, Croda J, Motta-Castro A. Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required. PLOS ONE 2019, 14: e0221265. PMID: 31437184, PMCID: PMC6705821, DOI: 10.1371/journal.pone.0221265.Peer-Reviewed Original ResearchConceptsHepatitis B virusSyphilis infectionViral hepatitisHIV infectionB virusAnti-HCV positive samplesChronic hepatitis B virusFirst-line anti-tuberculosis drugsLifetime syphilis infectionCases of tuberculosisAnti-TB drugsCross-sectional studyPublic health problemAnti-tuberculosis drugsCurrent HCVHCV exposureHCV RNAHepatitis testingTuberculosis infectionActive syphilisSerological markersEpidemiological featuresFrequent causeSide effectsHCV
2014
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, Pagano M, Becerra MC, Cohen T. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. The Lancet 2014, 383: 1572-1579. PMID: 24671080, PMCID: PMC4094366, DOI: 10.1016/s0140-6736(14)60195-1.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisMultidrug-resistant tuberculosis diseaseTreatment-naive adultsMultidrug-resistant diseaseTuberculosis diseaseTuberculosis incidenceGlobal incidenceSystematic reviewCases of tuberculosisHarvard Medical SchoolGlobal tuberculosis incidenceGlobal annual incidenceTuberculosis riskAnnual incidencePatient groupUS National InstitutesWomen's HospitalInclusion criteriaInternal medicineNew diagnostic instrumentDisease riskTuberculosisIncidenceDiseaseHealth equity
2013
Data needs for evidence-based decisions: a tuberculosis modeler's ‘wish list’ [Review article]
Dowdy DW, Dye C, Cohen T. Data needs for evidence-based decisions: a tuberculosis modeler's ‘wish list’ [Review article]. The International Journal Of Tuberculosis And Lung Disease 2013, 17: 866-877. PMID: 23743307, PMCID: PMC4041555, DOI: 10.5588/ijtld.12.0573.Peer-Reviewed Original Research
1998
Molecular and Geographic Patterns of Tuberculosis Transmission After 15 Years of Directly Observed Therapy
Bishai W, Graham N, Harrington S, Pope D, Hooper N, Astemborski J, Sheely L, Vlahov D, Glass G, Chaisson R. Molecular and Geographic Patterns of Tuberculosis Transmission After 15 Years of Directly Observed Therapy. JAMA 1998, 280: 1679-1684. PMID: 9831999, DOI: 10.1001/jama.280.19.1679.Peer-Reviewed Original ResearchConceptsEpidemiologic linkObserved therapyTuberculosis casesTuberculosis transmissionRecent transmissionTraditional contact investigationsCulture-positive tuberculosisTuberculosis control measuresCases of tuberculosisCommon risk factorsProportion of casesHigher drug useLow socioeconomic statusProportion of diseaseContact investigationEpidemiologic evidenceM tuberculosisRisk factorsEpidemiologic comparisonsEpidemiologic linkageTuberculosis accountsInformation system dataTraditional contact tracingDrug useEarly identification
1989
A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
Selwyn P, Hartel D, Lewis V, Schoenbaum E, Vermund S, Klein R, Walker A, Friedland G. A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection. New England Journal Of Medicine 1989, 320: 545-550. PMID: 2915665, DOI: 10.1056/nejm198903023200901.Peer-Reviewed Original ResearchConceptsHIV-seropositive subjectsIntravenous drug usersPositive PPD testHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionActive tuberculosisPPD testDrug usersSeronegative subjectsSeropositive subjectsTuberculous infectionSkin testingVirus infectionHIV-seronegative intravenous drug usersHIV-seronegative subjectsLatent tuberculous infectionRisk of tuberculosisTuberculin skin testingCases of tuberculosisMethadone maintenance programHIV antibodiesHIV-seropositiveHIV infectionProspective studyProtein derivative (PPD) tuberculin
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply